GRPR and Nephropathy: GRPR antagonists can inhibit several pro-inflammatory signaling pathways, prevent the secretion of pro-inflammatory cytokines, and reduce the infiltration of inflammatory cells, thereby mitigating renal inflammation and alleviating kidney damage [21].